These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 978396)

  • 1. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.
    Smolen VF
    J Pharmacokinet Biopharm; 1976 Aug; 4(4):337-53. PubMed ID: 978396
    [No Abstract]   [Full Text] [Related]  

  • 2. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.
    Smolen VF
    J Pharmacokinet Biopharm; 1976 Aug; 4(4):355-75. PubMed ID: 978397
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 5. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
    Lalka D; du Souich P; McLean AJ; Gibaldi M
    J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-effect curves and relative biophasic drug levels: elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response.
    Weigand WA; Jhawar AK
    J Pharmacokinet Biopharm; 1976 Feb; 4(1):67-80. PubMed ID: 1271241
    [No Abstract]   [Full Text] [Related]  

  • 12. History of pharmacokinetics.
    Wagner JG
    Pharmacol Ther; 1981; 12(3):537-62. PubMed ID: 7025032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological availability of drugs].
    Holovkin VO
    Farm Zh; 1979; (2):20-5. PubMed ID: 456507
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability from pharmaceutical dosage forms.
    Stenlake JB
    Analyst; 1974 Dec; 99(1185):824-37. PubMed ID: 4462405
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 17. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
    Xi NZ
    Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopharmaceutic and pharmacokinetic parameters in assessing pharmacopoeial drug quality standards (author's transl)].
    Zathurecký L
    Cas Lek Cesk; 1977 Apr; 116(16):481-5. PubMed ID: 872171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.